Chemed Corporation Earnings Report and Upcoming Conference Call

Author: Olivia Taylor Updated: 02-11-2025 05:44 PM

Chemed Corporation to Present Fourth Quarter Earnings

Chemed Corporation (NYSE: CHE) is set to unveil its financial performance for the fourth quarter that concluded on December 31, 2024. The results will be disclosed on February 26, 2025, after the market closes on the New York Stock Exchange. This event is a key moment for investors and market watchers alike, providing insights into the company's recent performance and strategic direction.

Details of the Conference Call

Following the earnings release, Chemed will conduct a conference call and a live webcast at 10 a.m. ET on February 27, 2025. This event will allow the leadership team to elaborate on the quarterly results and engage with stakeholders about the ongoing business strategies and market outlook.

How to Join the Conference Call

To participate, individuals can access the live broadcast via the investor relations section of Chemed’s official website. This is an exciting opportunity for investors to hear directly from the management team about the company's future expectations and performance highlights.

Conference Call Registration

For those wishing to register for the teleconference, there is a straightforward registration process. Once registered, attendees will receive a unique dial-in number along with a personalized conference code, ensuring a smooth entry to the call. It is advised to log in at least 15 minutes ahead of the scheduled start time.

Availability of Call Recording

A recording of the conference call will be accessible approximately two hours after its conclusion. This replay will be available through the investor relations section of Chemed’s website, providing an opportunity for those who were unable to attend the call live to catch up on the discussion.

About Chemed Corporation

Headquartered in Cincinnati, Chemed Corporation is listed on the New York Stock Exchange and operates two major subsidiaries: VITAS Healthcare and Roto-Rooter. VITAS is recognized as the leading provider of end-of-life hospice care services in the United States, delivering compassionate support to patients and families in critical times. In parallel, Roto-Rooter shines as the foremost provider of plumbing and drain cleaning services, ensuring households and businesses are well-maintained and operational.

Industry Outlook and Company Performance

Chemed Corporation, a well-respected name within the healthcare and home services sectors, is continually adapting to the evolving market dynamics. With an increasing demand for hospice services, VITAS Healthcare has positioned itself strongly as a community resource for families facing the challenges of end-of-life care. Simultaneously, Roto-Rooter's robust service offerings meet the critical home repair needs of countless customers each day, reinforcing Chemed's commitment to operational excellence.

Frequently Asked Questions

When will Chemed Corporation announce its fourth-quarter earnings?

Chemed Corporation will report its fourth-quarter earnings on February 26, 2025.

How can I listen to the earnings conference call?

The conference call will be accessible via Chemed’s investor relations website on February 27, 2025, at 10 a.m. ET.

Will there be a recording of the call available afterwards?

Yes, a taped replay of the conference call will be available on Chemed's website approximately two hours after the call ends.

What are the main services provided by Chemed Corporation?

Chemed Corporation operates VITAS Healthcare, specializing in hospice care, and Roto-Rooter, which provides plumbing and drain cleaning services.

Is Chemed Corporation publicly traded?

Yes, Chemed Corporation is publicly traded on the New York Stock Exchange under the ticker CHE.

About The Author

Olivia Taylor here, a 26-year-old writer and financial advisor. After earning a degree in finance, I worked in the sector for years. I've always loved numbers and had a talent for simplifying difficult financial ideas so that anyone could understand. I wrote my first book because of this passion; it helps readers take charge of their financial futures by fusing real-life stories with useful financial advice.

Whether they are just beginning their careers, preparing for significant life events, or seeking to invest wisely, my goal with my writing is to enable people to make educated financial decisions. The foundation of my work is the conviction that security and freedom of the individual are largely determined by financial literacy. To further financial education, I run workshops and frequently write for financial blogs in addition to my books.

I like to travel, experience other cultures, and find inspiration in daily life when I'm not writing or examining market trends. My passion is utilizing sound financial practices to help people reach their financial objectives and lead the best lives possible.

Contact Olivia Taylor privately here. Or send an email with ATTN: Olivia Taylor as the subject to contact@investorshangout.com.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.